Previous close | 37.88 |
Open | 6.06 |
Bid | 3.50 |
Ask | 8.00 |
Strike | 350.00 |
Expiry date | 2024-12-20 |
Day's range | 6.06 - 6.06 |
Contract range | N/A |
Volume | |
Open interest | 4 |
West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.
West Pharmaceutical (WST) delivered earnings and revenue surprises of -14.12% and 4.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.51. Earnings, adjusted for amortization costs, were $1.52 per share. The results missed Wall Street expectations.